Antiviral pathway activation in patients with chronic fatigue syndrome andacute infection

Citation
Jw. Gow et al., Antiviral pathway activation in patients with chronic fatigue syndrome andacute infection, CLIN INF D, 33(12), 2001, pp. 2080-2081
Citations number
7
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
CLINICAL INFECTIOUS DISEASES
ISSN journal
10584838 → ACNP
Volume
33
Issue
12
Year of publication
2001
Pages
2080 - 2081
Database
ISI
SICI code
1058-4838(200112)33:12<2080:APAIPW>2.0.ZU;2-Z
Abstract
Gene expression of key enzymes in 2 antiviral pathways (ribonuclease latent [RNase L] and RNA-regulated protein kinase [PKR]) was compared in 22 patie nts with chronic fatigue syndrome (CFS), 10 patients with acute gastroenter itis, and 21 healthy volunteers. Pathway activation in the group of patient s with infections differed significantly from that of the other 2 groups, i n whom there was no evidence of upregulation. Therefore, assay of activatio n is unlikely to provide the basis for a diagnostic test for CFS.